Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2
Explore topics from micro- and nanoscale LC-MS analysis to NGS sample quality control, EEM and A-TEEM spectroscopy, and oligonucleotide analysis
Innovation and growth remain a priority to support customers and COVID-19 initiatives
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Integrated fluorescence light microscope combines light and electron microscopy into one system, removes complication of transferring samples between microscopes
